Intra-Cellular Therapies (ITCI) Ownership - Who owns Intra-Cellular Therapies?

Industry: @Biotechnology
17 days until earnings call

Profile

Industry
Biotechnology
Address
430 East 29th Street
Phone
+1 646 440-9333
Employees
610
Web
https://www.intracellulartherapies.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
6.7B
P/E Ratio
N/A
Total Cash
497.94M
Projected Growth
N/A
Total Debt
16.94M
Revenue
462.18M
Risk (Beta)
0.88
Dividend Yield
N/A
Total Cash/Share
5.14
Total Debt/Equity
N/A
Revenue/Share
4.82 USD as % of share price

Fundamentals

ITCI
Capitalization
6.7B
P/E Ratio
N/A
Risk (Beta)
0.88
Dividend Yield
N/A
Total Cash
498M
Total Cash/Share
5.14
Total Debt
16.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.82%
Revenue
462M
ROE
N/A
Book Value
591M
P/B Ratio
11.17
Cash Flow
N/A
Earnings
-1.46
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
10K
Current Ratio
5.41
Current Revenue Per Employee
234413.55
Dividends Per Share - Security
N/A
EBITDA
-158.85M
Float
N/A
Float - Current
N/A
Gross Income Margin
91.86
Revenue To Assets
-18.84
Shares Held By Institutions
11.7B
Shares Outstanding - Current
96.8M
Total Liabilities
137M
Total Volume MTD
N/A
Value
-1
Gain YTD
4.524
View a ticker or compare two or three
ITCI
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
430 East 29th Street
Phone
+1 646 440-9333
Employees
610
Web
https://www.intracellulartherapies.com